Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by EbbFlow88on May 10, 2021 6:41pm
93 Views
Post# 33170503

RE:RE:RE:like a twig ...

RE:RE:RE:like a twig ...
wagyusteak wrote:
Chianchin wrote: The usual llosers are out in a swarm licking their wounds and crying out loud. Need not too worry of the past as the worst for GUD is yet to come as now they no longer have a lot of cash left  to go burn. Maybe GUD will do a pp at $1.50. Great deal


Not that this deserves any real time but I'll give it anyway. Saying GUD burns cash is wrong. It assumes they have losses. They don't. The price has gone down, but the company doesn't have any losses. Not from a net earnings perspective, nor a cash flow perpective. However, they have made accretive investments.


  Income Op Cash
2014 126M 0.8M
2015 34M 7.6M
2016 19M 14.7M
2017 17M 23.5M
2018 24M (5.7)M
2019 18M 4.6M
2020 32M (12.2)M
Total 270M 33.3M


We're heading towards the back end of Covid it seems and from last quarter, it looks like the worst is behind GBT. We will get more color on Friday regarding this. Even if the CDN dollar continues to strengthen it will just keep the positive GBT earnings lower on a relative basis, which is what is most likely keeping the stock down for now. 

<< Previous
Bullboard Posts
Next >>